Early Investigator Research Award Service

The government authority located in Washington, DC, is seeking early investigator research award services to advance the understanding and treatment of Parkinson's disease. The agency is trying to solve critical knowledge gaps by funding research into biological mechanisms or biomarkers, including clinical, fluid, imaging, tissue, and device indicators, that address unmet medical needs. This initiative aims to drive the development of novel treatments for Parkinson's disease across all stages, from prodromal to late-stage disease. The scope of work covers the development and characterization of in vitro model systems that approximate in vivo cellular and system complexity. Additionally, the project requires investigating how disease biological and clinical heterogeneity impacts disease presentation, clinical course, and therapeutic outcomes. The agency requires all performed work to take place offsite. Eligibility is strictly limited to onshore organizations based in the United States. The agency is currently looking for proposals to determine the budget and has not disclosed a specific funding limit or key dates in the initial solicitation. Evaluation will be based on the submitted proposals addressing these research areas.